Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Annals of Surgery|July 24, 2025
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA RegistryMaria Bencivenga, Kammy Keywani, Lorena Torroni, et al.
Annals of Surgical Oncology|July 27, 2025
Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort StudyKatarzyna Sędłak, Sebastian Kobiałka, Zuzanna Pelc, et al.
Nature Genetics|December 24, 2013
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaJessica Okosun, Csaba Bödör, Jun Wang, et al.
International Journal of Cancer|May 28, 2025
Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysisZuzanna Pelc, Katarzyna Sędłak, Radosław Mlak, et al.
Annals of Surgery|August 9, 2023
Textbook Oncological Outcome in European GASTRODATAKatarzyna Sędłak, Karol Rawicz-Pruszyński, Radosław Mlak, et al.
The Lancet. Haematology|January 29, 2021
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trialAndrés J M Ferreri, Jeanette K Doorduijn, Alessandro Re, et al.
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
Pageof 29